SCHEMBL232375

SCHEMBL232375

CN(c1ccc(Cl)cc1)c1ccc(C(=O)c2cc(C(=O)O)cc(C(=O)Nc3cc(F)ccc3F)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTC4S Q16873 2/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
SERPINE1 P05121 1/20 0.41
KCNMA1 Q12791 1/20 0.41
F10 P00742 1/20 0.40
SRD5A2 P31213 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TP53 P04637 1/20 0.39
PPARG P37231 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2743190 0.87 LTC4S (0.46) LTC4SMEN1KMT2AKDM4ESRD5A2
SCHEMBL231992 0.81 FFAR1 (0.50) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL233691 0.80 HTT (0.51) LTC4SMEN1KMT2ANPC1RAB9A
SCHEMBL2743182 0.79 MAPT (0.43) LTC4SNPC1RAB9AMAPTSRD5A2
SCHEMBL232237 0.79 SRD5A2 (0.56) LTC4SNPC1RAB9AMAPTSRD5A2
SCHEMBL230136 0.75 SRD5A2 (0.51) LTC4SNPC1RAB9ASRD5A2ALDH1A1
SCHEMBL232051 0.75 USP2 (0.53) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL2743197 0.75 LTC4S (0.43) LTC4SNPC1RAB9ASRD5A2HPGD
SCHEMBL2743184 0.75 SRD5A2 (0.47) LTC4SNPC1MAPTSRD5A2ALDH1A1
SCHEMBL231355 0.74 LTC4S (0.46) LTC4SMEN1KMT2ASRD5A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R LTC4S 1/4885MEN1 4355/4885KMT2A 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.